The Science
Behind Our Treatments
Behind Our Treatments
Safety And Efficacy Of Low-intensity Extracorporeal Shockwave In The Treatment Of Vasculogenic Erectile Dysfunction: A Multi-center, Double-blind, Randomized Sham-controlled Clinical Trial.
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
As a novel therapeutic method for erectile dysfunction (ED), low-intensity extracorporeal shock wave treatment (LI-ESWT) has been applied recently in the clinical setting.
Penile Low-Intensity Shock Wave Therapy: A Promising Novel Modality for Erectile Dysfunction
Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population
Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study
Low-Intensity Shockwave Therapy (LiST) for Erectile Dysfunction: Is It Safe for Patients on Anticoagulant Medication?
Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials
Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica
Determinants of Early Response to Low-Intensity Extracorporeal Shockwaves for the Treatment of Vasculogenic Erectile Dysfunction: An Open-Label, Prospective Study
Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors?
for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency)
YAG laser treatment on stress urinary incontinence in women: prospective cohort study
YAG laser treatment of stress urinary incontinence in women–a pilot study
Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence
atrophy (VVA) dyspareunia relief in breast cancer survivors
as a treatment for vulvovaginal atrophy (VVA) symptoms
for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women
Vulvo-Vaginal Atrophy (VVA) in Oncological Patients: Preliminary Results
breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study
for evaluating the efficacy of ReStore Fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women
(VVA) dyspareunia relief in breast cancer survivors
of a ReStore Fractional CO2 laser system for the treatment of vulvovaginal atrophy
and the genitourinary syndrome of menopause: An observational study
YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment
YAG Laser Using 90° and 360° Scanning Scopes: A Pilot Study & Short-term Results
in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study
Vestibulodynia and Genitourinary Syndrome of Menopause: A Pilot Study
treatment in women suffering from genitourinary syndrome of menopause
for the treatment of genitourinary syndrome of menopause: 1-year outcomes
thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors
the second-generation thermotherapy for the genitourinary syndrome of menopause
menopause in breast cancer survivors: clinical, immunological, and microbiological aspects
Postmenopausal Atrophic Vaginal Mucosa Following ReStore Fractional CO2 Laser Treatment
postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment
microablative ReStore Fractional CO2 laser on atrophic vaginal tissue: an ex vivo study
of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment
the second-generation thermotherapy for the genitourinary syndrome of menopause
YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause
for minimally invasive laser treatment of female stress urinary incontinence
of Human Postmenopausal Atrophic Vaginal Mucosa Following ReStore Fractional CO2 Laser Treatment
in Post-menopausal women with vaginal atrophy
Laser treatment for the management of genitourinary syndrome of menopause after breast cancer.
on the Quality of Life, General Health, and Genitourinary Symptoms in Postmenopausal Women With Vaginal Atrophy: A Prospective Cohort
on the vaginal health, microbiota, and cellularity of postmenopausal women
or Premarin Vaginal Cream on Improving Sexual Function in Menopausal Women: A Randomized Controlled Trial
ReStore Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy
for genitourinary syndrome of menopause in gynecologic cancer survivors
With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause.
A 12-week treatment with ReStore Fractional CO2 laser for vulvovaginal atrophy: a pilot study
The Effect of the CO2 Fractional Laser or Premarin Vaginal Cream on Improving Sexual Function in Menopausal Women
2505 E 3300 S
Ste 202
Salt Lake City, UT 84109
801-807-8811
Info@ReMedical.com
Monday – Friday 9am to 5pm
Saturday by Appointment
Get treatment for as little as…
HSA & Flex Spending Accounts Accepted